These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8094449)

  • 1. The long term stability of mechlorethamine hydrochloride (nitrogen mustard) ointment measured by HPLC.
    Cummings J; MacLellan A; Langdon SJ; Smyth JF
    J Pharm Pharmacol; 1993 Jan; 45(1):6-9. PubMed ID: 8094449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the nitrogen mustard mechlorethamine in topical pharmaceutical preparations by high-performance liquid chromatography.
    Reepmeyer JC
    J Chromatogr A; 2005 Sep; 1085(2):262-9. PubMed ID: 16106707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of the nitrogen mustard mechlorethamine in novel formulations for dermatological use.
    Ritschel WA; Ye W; Buhse L; Reepmeyer JC
    Int J Pharm; 2008 Oct; 362(1-2):67-73. PubMed ID: 18634862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modifications and insights into a method for the analysis of the nitrogen mustard mechlorethamine by high-performance liquid chromatography.
    Reepmeyer JC; Ye W; Ritschel WA
    Anal Chim Acta; 2008 May; 616(1):78-84. PubMed ID: 18471487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of mechlorethamine hydrochloride 0.01% ointment in aquaphor base.
    Zhang Y; Trissel LA; Johansen JF; Kimball CL
    Int J Pharm Compd; 1998; 2(1):89-91. PubMed ID: 23989487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechlorethamine hydrochloride solutions and ointment. Prolonged stability and biological activity.
    Taylor JR; Halprin KM; Levine V; Aoyagi T
    Arch Dermatol; 1980 Jul; 116(7):783-5. PubMed ID: 7396542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-performance liquid chromatographic assay for prostaglandin E1 in various ointment vehicles. Separation and stability testing.
    Yamamura K; Yotsuyanagi T
    J Chromatogr; 1984 Oct; 303(1):165-72. PubMed ID: 6542568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of Compounded Topical Nifedipine in Cream, Gel, and Ointment Bases.
    Teimouri A; Yeung P; Agu RU
    Int J Pharm Compd; 2021; 25(4):344-351. PubMed ID: 34297697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical nitrogen mustard ointment with occlusion for Langerhans' cell histiocytosis of the scalp.
    Treat JR; Suchin KR; James WD
    J Dermatolog Treat; 2003 Jan; 14(1):46-7. PubMed ID: 12745855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton magnetic resonance (PMR) spectroscopic determination of mechlorethamine hydrochloride for injection in commercial unit doses.
    Turczan J; Lau-Cam C
    Pharmazie; 1986 Nov; 41(11):775-6. PubMed ID: 3562509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of mycosis fungoides with ointment-based mechlorethamine.
    Price NM; Deneau DG; Hoppe RT
    Arch Dermatol; 1982 Apr; 118(4):234-7. PubMed ID: 7065680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical mechlorethamine in the treatment of mycosis fungoides. Uniformity of application and potential for environmental contamination.
    Breneman DL; Nartker AL; Ballman EA; Pruemer JM; Blumsack RF; Davis M; Breneman JC
    J Am Acad Dermatol; 1991 Dec; 25(6 Pt 1):1059-64. PubMed ID: 1844356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alkylation of guanosine by phosphoramide mustard, chloromethine hydrochloride and chlorambucil.
    Kallama S; Hemminki K
    Acta Pharmacol Toxicol (Copenh); 1984 Mar; 54(3):214-20. PubMed ID: 6720319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ointment-based mechlorethamine treatment for mycosis fungoides.
    Price NM; Hoppe RT; Deneau DG
    Cancer; 1983 Dec; 52(12):2214-9. PubMed ID: 6640491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of Compounded Diltiazem Hydrochloride in Cream, Ointment, and Gel Formulations for Topical Use.
    Teimouri A; Yeung P; Agu RU
    Int J Pharm Compd; 2020; 24(6):482-490. PubMed ID: 33217738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilities of 7-alkylguanosines and 7-deoxyguanosines formed by phosphoramide mustard and nitrogen mustard.
    Kallama S; Hemminki K
    Chem Biol Interact; 1986 Jan; 57(1):85-96. PubMed ID: 3948286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wipe selection for the analysis of surface materials containing chemical warfare agent nitrogen mustard degradation products by ultra-high pressure liquid chromatography-tandem mass spectrometry.
    Willison SA
    J Chromatogr A; 2012 Dec; 1270():72-9. PubMed ID: 23218189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of ibuprofen in ointments by reversed-phase liquid chromatography.
    Haikala VE; Heimonen IK; Vuorela HJ
    J Pharm Sci; 1991 May; 80(5):456-8. PubMed ID: 1880726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of reactive nitrogen mustard anticancer drugs in plasma by high-performance liquid chromatography using derivatization.
    Cummings J; MacLellan A; Smyth JF; Farmer PB
    Anal Chem; 1991 Aug; 63(15):1514-9. PubMed ID: 1952082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ointment bases on topical and transdermal delivery of salicylic acid in rats: evaluation by skin microdialysis.
    Murakami T; Yoshioka M; Okamoto I; Yumoto R; Higashi Y; Okahara K; Yata N
    J Pharm Pharmacol; 1998 Jan; 50(1):55-61. PubMed ID: 9504435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.